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Endocannabinoids and their receptor CB1 play key
roles in brain function. Astrocytes express CB1Rs
that are activated by endocannabinoids released
byneurons. However, the consequences of the endo-
cannabinoid-mediated neuron-astrocyte signaling
on synaptic transmission are unknown. We show
that endocannabinoids released by hippocampal
pyramidal neurons increase the probability of trans-
mitter release at CA3-CA1 synapses. This synaptic
potentiation is due to CB1R-induced Ca2+ elevations
in astrocytes, which stimulate the release of gluta-
mate that activates presynaptic metabotropic gluta-
mate receptors. While endocannabinoids induce
synaptic depression in the stimulated neuron by
direct activation of presynaptic CB1Rs, they indi-
rectly lead to synaptic potentiation in relatively more
distant neurons by activation of CB1Rs in astrocytes.
Hence, astrocyte calcium signal evoked by endoge-
nous stimuli (neuron-released endocannabinoids)
modulates synaptic transmission. Therefore, astro-
cytes respond to endocannabinoids that then
potentiate synaptic transmission, indicating that
astrocytes are actively involved in brain physiology.
INTRODUCTION
The endocannabinoid system is an important intercellular
signaling system involved in a wide variety of physiological
processes. Endocannabinoids and their receptor CB1 play
relevant neuromodulatory roles in brain physiology (Chevaleyre
et al., 2006; Freund et al., 2003) and are responsible for most
of the psychotropic and behavioral effects of cannabinoids
(Di Marzo et al., 1994; Maldonado et al., 2006). They mediate
retrograde inhibition of transmitter release, control neuronal
excitability, and regulate short- and long-term synaptic plasticity
(Chevaleyre et al., 2006; Freund et al., 2003; Alger, 2002; Kreitzer
and Regehr, 2002; Wilson and Nicoll, 2002). The effects of
endocannabinoids and CB1R activation on synaptic transmis-
sion have been largely characterized in many brain regions
(Chevaleyre et al., 2006; Heifets and Castillo, 2009; Kano et al.,
2009; Lovinger, 2008). Although a recent study in goldfish has
shown that CB1R activation stimulates the release of dopaminethat lead to the modulation of chemical and electrical synapses
in the Mauthner cell (Cachope et al., 2007), endocannabinoid
signaling is generally accepted to induce the inhibition of
neurotransmitter release from presynaptic terminals (Chevaleyre
et al., 2006; Hashimotodani et al., 2007).
Accumulating evidence has demonstrated the existence of
bidirectional communication between astrocytes and neurons
(Araque et al., 2001; Haydon and Carmignoto, 2006; Nedergaard
et al., 2003; Perea et al., 2009; Volterra and Bezzi, 2002).
Astrocytes respond with intracellular Ca2+ elevations to neuro-
transmitters released by synaptic terminals (Perea and Araque,
2005; Porter and McCarthy, 1996) and, in turn, modulate
neuronal excitability and synaptic transmission by releasing
neuroactive substances called gliotransmitters (Volterra and
Bezzi, 2002; Araque et al., 1999; Beattie et al., 2002; Perea
and Araque, 2007).
Cannabinoid effects in brain physiology have been largely
thought to be mediated by CB1Rs exclusively present in
neurons. However, hippocampal astrocytes have recently
shown to express functional CB1Rs that upon activation by
endocannabinoids released from pyramidal neurons increase
the astrocyte Ca2+ levels and stimulate the release of glutamate,
which, in turn, leads to themodulation of the neuronal excitability
through activation of NMDARs in neurons (Navarrete and
Araque, 2008). However, the consequences of the endocannabi-
noid-mediated neuron-astrocyte communication on synaptic
transmission remain unknown.
Therefore, we used electrophysiological and Ca2+ imaging
techniques in mice brain slices to investigate the effects of
the endocannabinoid-mediated neuron-astrocyte signaling on
synaptic transmission at hippocampal synapses. We performed
paired recordings from CA1 pyramidal neurons, monitored
astrocyte Ca2+ levels, and stimulated Schaffer collaterals using
the minimal stimulation technique that activates single or very
few presynaptic fibers (Dobrunz and Stevens, 1997; Isaac
et al., 1996; Perea and Araque, 2007; Raastad, 1995). We found
that endocannabinoids released by hippocampal pyramidal
neurons increase the probability of transmitter release at
CA3-CA1 synapses by triggering a cascade of signaling events
consisting in activation of CB1Rs in adjacent astrocytes, eleva-
tion of their Ca2+ levels, stimulation of glutamate release and
activation of presynaptic metabotropic glutamate receptor
type 1. While endocannabinoids directly induced Gi/o protein-
mediated synaptic depression in synapses close to the source
of endocannabinoids (i.e., synapses in the neuron that release
endocannabinoids and nearby synapses) by activation of
presynaptic CB1Rs, they indirectly led to synaptic potentiationNeuron 68, 113–126, October 7, 2010 ª2010 Elsevier Inc. 113
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Glia-Mediated Synaptic Modulation by Cannabinoidsin relatively more distant synapses (i.e., synapses in other
neurons not releasing endocannabinoids) by activation of
astrocytes.
RESULTS
We first quantified the synaptic transmission properties of the
excitatory postsynaptic currents (EPSCs) in our experimental
conditions (Figures 1A–1D). Synaptic responses showed failures
and successes in neurotransmitter release (probability of
release, Pr, was 0.31 ± 0.02; range, 0.07–0.83; n = 53 synapses),
regular amplitude of successful responses (termed synaptic
potency; 11.9 ± 0.6 pA; range, 4.1–25.5 pA; n = 53) and relatively
low synaptic efficacy (i.e., mean amplitude of all responses
including failures: 7.7 ± 0.90 pA; range, 0.9–18.4 pA; n = 53)
(cf. Dobrunz and Stevens, 1997; Isaac et al., 1996; Perea and
Araque, 2007).
Then, we depolarized one pyramidal neuron to 0 mV for 5 s to
stimulate endocannabinoid release (Chevaleyre and Castillo,
2004; Kreitzer and Regehr, 2001; Ohno-Shosaku et al., 2001;
Wilson and Nicoll, 2001), and monitored synaptic transmission
at synapses in an adjacent neuron. In 14 out of 51experiments
(27%), neuronal depolarization (ND) transiently increased Pr
(from 0.24 ± 0.04 to 0.47 ± 0.05; n = 14; p < 0.01) without
changing the synaptic potency (from 12.1 ± 1.2 pA to 13.0 ±
2.0 pA; n = 14; p = 0.57), which resulted in a transient enhance-
ment of the synaptic efficacy (from 4.8 ± 1.6 pA to 9.2 ± 1.6 pA;
n = 14; p < 0.01) (Figure 1E). These effects were associated with
changes in thepaired-pulse facilitation, suggesting a presynaptic
origin, and were reliably evoked by successive ND (Figure S1).
In other 14 out of the 51 cases, ND evoked a transient
decrease of Pr (from 0.30 ± 0.06 to 0.18 ± 0.04; n = 14; p <
0.05) without changing the synaptic potency (from 10.8 ±
3.8 pA to 9.7 ± 2.7 pA; n = 14; p = 0.35), which led to a transient
decrease of the synaptic efficacy (from 5.3 ± 1.2 pA to 2.8 ±
0.7 pA; n = 14; p < 0.01) (Figure 2). In synapses that showed
ND-evoked depression of synaptic transmission in control,
subsequent perfusion with the CB1R antagonist AM251 (2 mM)
abolished this effect, which is similar to the depolarization-
induced suppression of excitation (DSE), and which is due to
activation of presynaptic CB1Rs (Chevaleyre et al., 2006; Kreit-
zer and Regehr, 2001; Ohno-Shosaku et al., 2002).
We then investigated if endocannabinoids mediated the
synaptic potentiation (e-SP) of transmitter release. Because
the appearance of ND-evoked DSE and e-SP were reliably
induced, to characterize pharmacologically both phenomena
we first identified specific synapses undergoing either DSE or
e-SP in control conditions and then analyzed the effects of
subsequent superfusion of pharmacological agents on those
identified synapses (unless stated otherwise). The ND-evoked
e-SP observed in control recordings was abolished after perfu-
sion with the CB1R antagonist AM251 (n = 6; Figures 1C, 1D,
and 1F), strongly suggesting that the ND-evoked e-SP is
mediated by endocannabinoids released from the postsynaptic
neuron.
Furthermore, e-SP was absent when the depolarized neuron
was dialyzed with 40 mM BAPTA (Chevaleyre et al., 2006;
Kreitzer and Regehr, 2001; Navarrete and Araque, 2008;114 Neuron 68, 113–126, October 7, 2010 ª2010 Elsevier Inc.Ohno-Shosaku et al., 2002; Wilson and Nicoll, 2001) (which
prevents endocannabinoid release; n = 11; Figures 1F and 1G),
or in slices from transgenic mice lacking CB1Rs (Zimmer et al.,
1999) (n = 13; Figures 1F and 1G). Likewise, DSEwas also absent
in these conditions (n = 11 and 13 synapses in BAPTA-filled
neurons and transgenic mice, respectively) (Figures 2E and
2F). Although no identifying control recordings were possible in
these experiments, the total absence of ND-evoked e-SP or
DSE further supports the idea that they are mediated by
endocannabinoids released from the postsynaptic neuron.
We then investigated whether action potential (AP) generation
could similarly evoke e-SP and DSE. We recorded the stimu-
lating neuron in current-clamp conditions and applied depolariz-
ing pulses that generated trains of APs. In 36 experiments under
these conditions, AP trains induced e-SP in 14 cases (39%) and
DSE in other 12 cases (33%) (Figures 3A–3E). Both AP-evoked
e-SP and DSE were abolished after perfusion with AM251 (n = 6
and 5, respectively) (Figures 3D and 3E). Furthermore, in some
cases (n = 11), we first recorded the postsynaptic neuron in
voltage-clamp conditions to identify synapses displaying
ND-evoked e-SP or DSE, and then we recorded the stimulating
neuron in current-clamp conditions and applied depolarizing
pulses. In these conditions, synapses displaying e-SP or DSE
after ND also displayed the respective synaptic modulation after
AP generation (n = 5 and 3 synapses, respectively). These results
indicate that ND and APs similarly evoked e-SP and DSE.
We next determined the dependence of the e-SP and DSE on
the neuronal activity level by applying depolarizing pulses of
different durations that evoked different number of APs. Fig-
ure 3F shows that the degree of e-SP and DSE in previously
identified synapses increased as the number of APs increased.
These results indicate that both synaptic phenomena can be
evoked by more physiological stimuli (i.e., postsynaptic action
potentials) and that they depend on the level of neuronal activity.
Because endocannabinoid signaling may be affected by the
external temperature, we analyzed the e-SP at 24C and 34C.
The ND-evoked potentiation of synaptic efficacy and Pr was
similarly present at both temperatures (Figure S3), indicating
that the ND-evoked e-SP was also present at a more physiolog-
ical temperature.
Endocannabinoid-Induced Synaptic Potentiation
Requires Astrocyte Calcium Elevations
Because endocannabinoids elevate astrocyte Ca2+ through
CB1R activation (Navarrete and Araque, 2008), and astrocytic
Ca2+ stimulates the release of gliotransmitters that modulate
synaptic transmission (Araque et al., 1998; Haydon and
Carmignoto, 2006; Perea and Araque, 2005, 2007; Volterra and
Meldolesi, 2005), we investigated if the e-SP required astrocyte
Ca2+ elevations. We first confirmed that endocannabinoids
released by pyramidal neurons signal to adjacent astrocytes.
The astrocyte Ca2+ signal, quantified from the Ca2+ spike prob-
ability, was increased after ND or AP firing, and this effect was
abolishedbyAM251 (cf. Navarrete andAraque, 2008) (FigureS2).
Then we tested whether astrocyte Ca2+ was required to induce
e-SP. Thapsigargin (1 mM), which depletes the intracellular
Ca2+ stores by inhibiting the Ca2+ ATPase (Navarrete and
Araque, 2008; Perea and Araque, 2005), abolished both the
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Figure 1. Endocannabinoids Potentiate
Transmitter Release at Hippocampal CA3-
CA1 Synapses
(A) Infrared differential interference contrast (DIC)
image showing paired recorded CA1 pyramidal
neurons and the stimulation electrode (bottom).
Scale bar, 40 mm.
(B) Schematic drawing depicting paired record-
ings from pyramidal neurons and the stimulating
electrode. ND, neuronal depolarization.
(C) Responses evoked by minimal stimulation
showing regular EPSC amplitudes and failures of
synaptic transmission (20 consecutive stimuli)
(top traces) and averaged EPSCs (n = 50 stimuli,
including successes and failures; bottom traces)
before (basal) and after ND in control and after
perfusion with 2 mM AM251.
(D) EPSC amplitudes from a representative
synapse in control and AM251. Zero time corre-
sponds to the beginning of ND, as in E and all other
figures.
(E) Synaptic efficacy (i.e., mean amplitude of
responses including successes and failures of
neurotransmission), probability of neurotrans-
mitter release (Pr) and synaptic potency (i.e.,
mean EPSC amplitude excluding failures) versus
time (bin width, 33 s; n = 14).
(F) Relative changes from control basal values of
synaptic parameters before (basal) and after ND
in control (n = 14), AM251 (n = 6), BAPTA-loaded
neuron (n = 11) and in hippocampal slices from
transgenic mice lacking CB1Rs (n = 13).
In (E) and (F), only synapses that displayed e-SP in
control were considered, except in BAPTA-loaded
neurons and CB1R/, in which all recorded
synapses were considered because previous
identification of synapses in control was unfea-
sible (see text).
(G) Proportion of synapses that showed e-SP after
ND in control (n = 51), in BAPTA-loaded neurons
(n = 11), and CB1R/ (n = 13).
**p < 0.01 and ***p < 0.001. Error bars indicate
SEM.
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Figure 2. Endocannabinoids Depress
Transmitter Release at Hippocampal CA3-
CA1 Synapses
(A) Schematic drawing depicting paired record-
ings from pyramidal neurons and the stimulating
electrode. ND, neuronal depolarization.
(B) Responses evoked by minimal stimulation (20
consecutive stimuli) (top traces) and averaged
EPSCs (n = 50 stimuli; bottom traces) before
(basal) and after ND in control and in 2 mMAM251.
(C) EPSC amplitudes from a representative
synapse. Zero time corresponds to the beginning
of ND.
(D) Synaptic efficacy, Pr, and synaptic potency
versus time (n = 14).
(E) Relative changes from control basal values of
synaptic parameters before (basal) and after ND
in control (n = 14), AM251 (n = 9), BAPTA-loaded
neuron (n = 11), and in hippocampal slices from
transgenic mice lacking CB1Rs (n = 13).
In (D) and (E), only synapses that displayed DSE in
control were considered, except in BAPTA-loaded
neurons and CB1R/, in which all recorded
synapses were considered because previous
identification of synapses in control was unfea-
sible (see text).
(F) Proportion of synapses that showed DSE after
ND in control (n = 51), in BAPTA-loaded neurons
(n = 11), and CB1R/ (n = 13).
**p < 0.01 and ***p < 0.001. Error bars indicate
SEM.
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Figure 3. Endocannabinoid-Induced Synaptic
Modulation Is Triggered by Action Potentials
and Depends on the Neuronal Activity Level
(A) Responses evoked by minimal stimulation
(20 consecutive stimuli) (top traces) and averaged
EPSCs (n = 50 stimuli; bottom traces) before (basal)
and after evoking trains of action potentials in current
clamp conditions in two different synapses (left and
right).
(B) EPSC amplitudes from representative synapses.
Zero time corresponds to the beginning of AP train.
(C) Pr versus time in different synapses that displayed
either e-SP (left; n = 14) or DSE (right; n = 12) in control.
(D and E) Relative changes from control basal values of
synaptic parameters before (basal) and after APs in
synapses that displayed either e-SP (n = 5) or DSE
(n = 6), respectively, in control and after perfusion
with AM251. Synapses displaying e-SP or DSE were
identified in control.
(F) Relative changes from control basal values of Pr
versus number of APs elicited by stimulation of pyra-
midal neurons with depolarizing pulses of variable
durations that evoked trains of APs (inset) in current
clamp conditions. Synapses were identified as showing
DSE (open circles) or e-SP (filled circles).
*p < 0.05, **p < 0.01 and ***p < 0.001. Each value
represents mean ± SEM of at least four synapses.
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Glia-Mediated Synaptic Modulation by Cannabinoidsendocannabinoid-evoked astrocyte Ca2+ elevations (Navarrete
and Araque, 2008) (Figures 4A–4C) and the e-SP (n = 7 cases
that showed e-SP before thapsigargin perfusion; Figures 4D–
4G). In contrast, the endocannabinoid-induced DSE observed
in other 5 cases in control was unaffected (Figure S4). These
results suggest that e-SP, but not DSE, requires astrocyte
Ca2+ elevations.
Because thapsigargin may not specifically act on astrocytes,
to confirm this idea we specifically prevented Ca2+ elevations in
astrocytes by including the Ca2+ chelator BAPTA (40 mM) in the
astrocyte whole-cell recording pipette (Figures 5A-5D), because
BAPTA dialyzed in a single hippocampal astrocyte is known to
spread to a large number of gap-junction connected astrocytes
(Jourdain et al., 2007; Serrano et al., 2006; Shigetomi et al.,
2008). After confirming that ND-evoked astrocyte Ca2+ eleva-
tions were prevented in an area at least 150 mm around the
recorded astrocyte (Figure 5C), we tested the consequences of
BAPTA dialysis into the astrocyte network. Because previous
identification of synaptic modulatory effects in control resulted
unfeasible, in these experiments we compared the incidence of
DSEande-SP (i.e., theproportion of synapses that showedeither
phenomenon) versus control slices. In 15 recordings under these
conditions, ND induced DSE in 6 cases (i.e., 40% versus 27% in
control; p > 0.05), but failed to induce e-SP in any of the 15 cases
(0% versus 27% in control; p < 0.001) (Figures 5D, 5G and 5H).
We further confirmed the involvement of astrocytes in the
synaptic modulation by including 10 mM GDPbS, which
prevents G protein-mediated intracellular signaling, in the astro-
cyte whole-cell recording pipette (Figures 5E–5H). Like BAPTA,
GDPbS dialyzed in a single hippocampal astrocyte could likely
spread to a large number of gap-junction connected astrocytes,
due to its relatively lowmolecular weight. We first confirmed that
ND-evoked astrocyte Ca2+ elevations were prevented in an area
at least 150 mm around the recorded astrocyte (Figure 5E), and
then we analyzed the consequences of GDPbS dialysis into the
astrocyte network, comparing the incidence of DSE and e-SP
versus control slices (because previous identification of synaptic
modulatory phenomena in control was unfeasible). In 16 record-
ings under these conditions, ND induced DSE in 6 cases
(i.e., 37% versus 27% in control; p > 0.05), but failed to induce
e-SP (only 1 out of 16 displayed e-SP, i.e., 6% versus 27% in
control; p < 0.001) (Figures 5F–5H). Altogether, these results
indicate that G protein-mediated astrocyte Ca2+ elevations are
not involved in DSE (cf. Beierlein and Regehr, 2006) but they
are required to induce e-SP.
Endocannabinoid-Induced Synaptic Potentiation Is
Mediated by Metabotropic Glutamate Receptor Type 1
Because astrocyte Ca2+ elevations stimulate the release of
glutamate which activating presynaptic metabotropic glutamate
receptors (mGluRs) potentiates synaptic transmitter release
(Perea and Araque, 2007), we investigated if that mechanism
was responsible for the e-SP. After identifying synapses that
transiently increased Pr upon ND in control, we perfused the
antagonists of group I mGluRs MPEP (50 mM) and LY367385
(100 mM; mGluR5 and mGluR1 antagonists, respectively). They
blocked the e-SP (in control, Pr = 0.33 ± 0.05 and 0.55 ± 0.09
and in MPEP+LY, Pr = 0.27 ± 0.05 and 0.29 ± 0.06, before and118 Neuron 68, 113–126, October 7, 2010 ª2010 Elsevier Inc.after ND, respectively; n = 7; not shown) without affecting the
ND-evoked astrocyte Ca2+ signal (not shown; cf. Navarrete
and Araque, 2008). Likewise, e-SP evoked by postsynaptic AP
generation was blocked by these mGluR antagonists (in control,
Pr = 0.35 ± 0.02 and 0.55 ± 0.02, and in MPEP+LY, Pr = 0.33 ±
0.03 and 0.31 ± 0.02 before and after APs, respectively; n = 5).
These results indicate that e-SP was mediated by activation of
group I mGluRs.
We next investigated the subtype of mGluR involved by
perfusing separately the group I mGluR antagonists (Figure 6).
While LY367385 abolished the ND-evoked e-SP previously
observed in control (Figures 6D–6G) without modifying the
astrocyte Ca2+ signal (Figure 6A-6C), MPEP did not prevent
e-SP (Figure 6H), indicating that e-SP was specifically mediated
by activation of type 1 mGluRs.
To confirm that e-SP was mediated by glutamate released
from astrocytes stimulated by endocannabinoids, and not by
direct presynaptic CB1R activation, we used two experimental
approaches. First, we monitored synaptic transmission and
selectively increased intracellular Ca2+ in astrocytes by whole-
cell recording single astrocytes that were loaded with the
Ca2+-cage NP-EGTA (5 mM) through the recording pipette.
UV-flash photolysis consistently elevated Ca2+ in the recorded
astrocyte and increased Pr (from 0.48 ± 0.11 to 0.65 ± 0.05;
n = 8; p < 0.01) in 8 out of 14 recorded synapses (cf. Perea
and Araque, 2007). In agreement with previous report (Perea
and Araque, 2007), this astrocyte-induced synaptic potentiation
was still present after perfussing with AM251, but was abolished
by group I mGluR antagonists (n = 8 and n = 5, respectively;
Figure S5). Second, in the presence of AM251 to block CB1Rs,
we directly applied the mGluR agonist DHPG while monitoring
synaptic transmission properties. To prevent possible effects
mediated by postsynaptic activation of mGluRs, recorded neu-
rons were dialyzed with 2 mM GDPbS included in the recording
pipette. Consistent with several reports (e.g., Faas et al., 2002;
Chevaleyre and Castillo, 2003), slow activation of mGluRs by
perfusion with 50 mM DHPG depressed synaptic transmission
(n = 5 synapses; see Figure S6). In contrast, a transient increase
of Pr was observed in 8 out of 15 recorded synapses by fast local
application of DHPG delivered by pressure pulses (0.5 s) through
amicropipette (Figure S6; in the other 3 and 4 cases out of the 15
recorded synapses Pr was decreased or unchanged, respec-
tively). This effect was abolished after perfusion with group I
mGluR antagonists (n = 5; Figures S6C–S6F), but no with
LY367385 alone (n = 4; not shown), indicating that the synaptic
potentiation evoked by exogenous glutamate receptor agonists
involved mGluR1 and mGluR5, whereas e-SP induced by astro-
cytic glutamate selectively involved mGluR1 (see Figure 6).
Differences in the effects of DHPG observed by delivery through
perfusion or pressure pulses may be accounted for by the
different application kinetics that may lead to inhibition or
facilitation of transmitter release (Rodrı´guez-Moreno et al., 1998;
Sa´nchez-Prieto et al., 2004). In summary, e-SPwas abolished by
mGluR antagonists, Ca2+ elevations in astrocytes induced
CB1R-insensitive and mGluR-dependent increase of transmitter
release, and mGluR activation could transiently enhance trans-
mitter release. Therefore, these results indicate that e-SP is
mediated by mGluR activation (Figure 6I).
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Figure 4. Intracellular Ca2+ Mobilization Is Necessary for the
Endocannabinoid-Induced Synaptic Potentiation
(A) Pseudocolor images representing fluorescence intensities of fluo 4-filled
astrocytes before (basal) and after ND in control and thapsigargin. Scale
bar, 20 mm.
(B) Ca2+ levels from six astrocytes in a field of view and corresponding
averaged traces (red) in control and thapsigargin. Horizontal bars indicate ND.
(C) Astrocyte Ca2+ spike probability in control and thapsigargin (44 astrocytes
from n = 7 slices). Zero time corresponds to the beginning of ND.
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Glia-Mediated Synaptic Modulation by CannabinoidsWhile group I mGluRs are coupled to pertussis toxin (PTX)-
insensitive Gq/11 proteins (Conn and Pin, 1997; Miura et al.,
2002), CB1Rs in neurons are mainly coupled to PTX-sensitive
Gi/o proteins (Chevaleyre et al., 2006; Mackie and Hille, 1992;
Piomelli, 2003). We then investigated the nature of the G protein
involved by preincubating the slices with 7.5 mg/ml PTX for
3.5–9 hr. Because the long incubation time prevented the
previous identification of synapses in control, we compared the
incidence of DSE and e-SP in parallel control and PTX treated
slices. In 9 PTX treated slices, only 2 out of 21 (9%) synapses
showed DSE (versus 6 out of 16 synapses, 37%, in 6 parallel
untreated slices; p < 0.001). In contrast, ND-evoked e-SP
occurred in 12 out of 21 synapses from 9 PTX-treated slices
(57%versus 33% in 6 parallel control slices; p < 0.01) (Figures 7A
and 7B). These results indicate that (1) Gi/o proteins mediate the
CB1R-induced DSE; (2) e-SP is mediated by activation of type I
mGluRs coupled to a PTX-insensitive G protein; and (3) e-SP
requiresPTX-insensitiveCB1R-mediated signaling. Furthermore,
the higher proportion of synapses that showed e-SP in PTX-
treated slices compared to control indicates that more synapses
were potentiated after blocking the CB1R-mediated intracellular
signaling, suggesting that in control conditions this signaling
prevails over the mGluR-mediated signaling (see below).
The Sign of the Endocannabinoid-Induced Synaptic
Modulation Does Not Depend on Differential Expression
of CB1Rs but on Specific Intercellular Signaling
Pathways
To investigate if the sign of the endocannabinoid-induced
synaptic modulation (i.e., DSE or e-SP) was due to differential
expression of CB1Rs by synaptic terminals or to specific inter-
cellular signaling pathways, we asked whether synapses that
showed e-SP could be depressed by activation of CB1Rs. We
performed control recordings, and after assessing that the
recorded synapse showed e-SP, we perfused the CB1R agonist
WIN55-212,2 (5 mM). In all the seven synapses that displayed
e-SP, WIN application depressed synaptic efficacy (Figures 7C–
7E). Although we cannot exclude that WIN effects on basal
synaptic transmission might be due to increasing action poten-
tial conduction failures, the fact that ND-evoked e-SP was
prevented by WIN (Figure 7C–7E) indicates that synapses that
showed e-SP also expressed CB1Rs linked to intracellular
cascades that can lead to synaptic depression, but these recep-
tors were probably spared from the released endocannabinoids.
Furthermore, this result along with the facts that WIN-treated
synapses no longer showed e-SP after ND (Figures 7C–7E)
and that the incidence of e-SP was higher in PTX-treated slices
(see above) indicate that direct activation of presynaptic CB1Rs,
which leads to DSE, overpowers the mGluR-mediated signaling
that leads to e-SP.(D)Mean EPSCs (n = 50) evoked byminimal stimulation before (basal) and after
ND in control and thapsigargin.
(E) EPSC amplitudes from a representative synapse in control and thapsigargin.
(F) Relative changes from control basal values of synaptic parameters before
(basal) and after ND in synapses that displayed e-SP in control and thapsigar-
gin (n = 7). *p < 0.05. Error bars indicate SEM.
(G) Proportion of synapses that showed DSE or e-SP after ND in control and
thapsigargin (n = 17). ***p < 0.001.
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Figure 5. Endocannabinoid-Induced Synaptic Potentiation Requires
Astrocyte Ca2+ Elevations
(A) Infrared DIC image showing paired recorded neurons, recorded astrocyte
(bottom, left) and the stimulation electrode (bottom, right).
(B) Schematic drawing depicting BAPTA dialysis into the astrocytic network
from the recorded astrocyte.
(C) (Left) Images representing fluorescence intensities of astrocytes before and
after ND in BAPTA-loaded astrocytes. (Right) Astrocyte Ca2+ spike probability
in BAPTA-filled astrocytes (116 astrocytes from n = 15 slices). Zero time
corresponds to the beginning of ND.
(D) Synaptic efficacy, Pr and synaptic potency in slices with BAPTA-filled
astrocytes (n = 9).
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Depression and Heteroneuronal Synaptic Potentiation
While endocannabinoids released by neurons exert their effects
at short-distances (<20 mm; Chevaleyre et al., 2006; Chevaleyre
and Castillo, 2004; Piomelli, 2003; Wilson and Nicoll, 2001), the
astrocyte Ca2+ signal, which spreads along the cell, may have
long-distance neuromodulatory effects by releasing gliotrans-
mitters at distal regions (Perea and Araque, 2005; Serrano
et al., 2006). We therefore hypothesized that endocannabinoids
released by ND depress synaptic transmission acting directly on
CB1Rs at near synaptic terminals, whereas they potentiate more
distant synapses through activation of astrocytic CB1Rs, which
leads to Ca2+ elevations in astrocytes that spread intracellularly
and stimulate glutamate release at distant sites. To test this
hypothesis we investigated the spatial profile of the endocanna-
binoid-mediated synaptic modulation, i.e., the appearance of
DSE and e-SP in synapses as a function of distance from the
neighboring stimulated neuron (Figure 8A; because the exact
location of synapses could not be determined, the distance of
synapses was estimated from the distance of the somas of the
stimulating and recording neurons). While most of the synapses
displaying DSE (i.e., Pr < 100% from basal values) were located
at relatively short distances from the stimulated neuron, those
undergoing e-SP (i.e., Pr > 100%) were located at relatively
longer distances.
To investigate the possible functional consequences of the
spatial segregation of both synaptic modulatory phenomena,
we analyzed the simultaneous effects of endocannabinoids on
the synaptic properties of synapses in the depolarized neuron
(homoneuronal synapses) and in the non-stimulated neuron (het-
eroneuronal synapses) (Figures 8B–8E). In 33 paired recorded
synapses, ND induced DSE in 13 homoneuronal synapses
(39%; Figure S7), but e-SP was never observed (0%). Contrast-
ingly, in heteroneuronal synapses, 10 showed DSE (30%) and 9
displayed e-SP (27%; n = 33; Figures 8B–8E).
The absence of e-SP in homoneuronal synapses is consistent
with the short range direct effect of endocannabinoids and
the prevalence of CB1R- over mGluR-mediated signaling. These
ideas predict that e-SP in homoneuronal synapses would be
canceled by the CB1R-mediated signaling but could be un-
masked by blocking this signaling cascade. To test this hypoth-
esis, we analyzed the incidence of e-SP in homoneuronal
synapses from 9 slices treated with PTX. In these slices, DSE
occurred in only 3 out of 21 homoneuronal synapses (versus
13 out of 33 in control slices; i.e., 14% versus 39%; p < 0.001),(E) (Left) Images representing fluorescence intensities of astrocytes before and
after ND in GDPbS-loaded astrocytes. (Right) Astrocyte Ca2+ spike probability
in GDPbS-filled astrocytes (146 astrocytes, n = 16 slices).
(F) Synaptic efficacy, Pr and synaptic potency in slices with GDPbS-filled
astrocytes (n = 10).
(G) Relative changes from control basal values of synaptic parameters after ND
in slices with BAPTA- (n = 9) and GDPbS-loaded astrocytes (n = 10).
In (D), (F), and (G), only synapses that did not display DSE were considered
because previous identification of synapses in control was unfeasible (see
text).
(H) Proportion of synapses that showedDSE or e-SP after ND in control (n = 51)
and in slices with BAPTA- (n = 15) and GDPbS-loaded astrocytes (n = 16).
***p < 0.001. Error bars indicate SEM. Scale bars, 20 mm.
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Figure 6. Endocannabinoid-Evoked Astrocyte-Induced Synaptic
Potentiation Is Mediated by mGluR Type 1
(A) Pseudocolor images representing astrocyte fluorescence intensities before
(basal) and after ND in control and in the presence of the mGluR type 1 antag-
onist LY367385. Scale bar, 20 mm.
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Glia-Mediated Synaptic Modulation by Cannabinoidsconfirming that the CB1R-mediated signaling was blocked. In
this condition, e-SP, which was absent in 33 control homoneuro-
nal synapses, was present in 4 out of 13 homoneuronal synapses
(i.e., 31% in PTX-treated slices versus 0% in control slices;
p < 0.001).
Taken together, these results indicate that synaptic modula-
tion by endocannabinoids is spatially-controlled and results
from activation of specific intracellular signals, i.e., short-range
direct activation of presynaptic CB1Rs or long-range indirect
activation of mGluRs through stimulation of astrocytes
(Figure 8F).DISCUSSION
Present results indicate that endocannabinoids may have
opposite neuromodulatory effects, depressing synaptic trans-
mission by directly acting on presynaptic CB1Rs or potentiating
synaptic transmission by acting on astrocytic CB1Rs that
stimulate glutamate release from astrocytes. While endocanna-
binoids are known to exert their direct inhibitory effects at
short-distances (<20 mm; see Chevaleyre et al., 2006; Cheva-
leyre and Castillo, 2004; Piomelli, 2003; Wilson and Nicoll,
2001), our results suggest that the effects of endocannabinoid
signaling are spatially prolonged by the endocannabinoid-
induced astrocyte Ca2+ signal, which spreading along the cell
may have long-distance neuromodulatory effects by releasing
gliotransmitters at distal regions (Perea and Araque, 2005;
Serrano et al., 2006). Therefore, endocannabinoids represent
a short-range signal that lead to direct depression of synapses
close to the endocannabinoid source, but by stimulating astro-
cytes they trigger a long-range signal (i.e., the astrocyte intracel-
lular Ca2+ that triggers glutamate release) that indirectly lead to
synaptic potentiation of relatively more distant synapses.
While CB1R activation by endocannabinoids is well known to
induce synaptic depression in many brain regions (Chevaleyre
et al., 2006; Kano et al., 2009; Heifets andCastillo, 2009), present
data indicate that endocannabinoids may lead to the potentia-
tion of hippocampal synaptic transmission. This synaptic
potentiation is an indirect effect mediated by the stimulation of
astrocytes that then release the gliotransmitter glutamate. Like-
wise, it has been recently reported that endocannabinoids may(B) Astrocyte Ca2+ spike probability versus time in control and LY367385 (n = 6
slices). Zero time corresponds to the beginning of the ND.
(C) Astrocyte Ca2+ oscillation frequency before (basal) and after ND in control
and LY367385 (n = 6 slices).
(D) Responses evoked by minimal stimulation (20 consecutive stimuli; top
traces) and averaged EPSCs (n = 50 stimuli; bottom traces) before (basal)
and after ND in control and LY367385.
(E) EPSC amplitudes from a representative synapse in control and LY367385.
(F) Pr versus time in control and after perfusion with LY367385 (n = 6).
(G and H) Relative changes from control basal values of synaptic parameters
before (basal) and after ND in control and in the presence of LY367385 (n = 6)
and MPEP (n = 7), respectively. *p < 0.05, **p < 0.01. Error bars indicate SEM.
(I) Schematic drawing representing the endocannabinoid-mediated neuron-
astrocyte signaling. Endocannabinoids (ECB) released by a pyramidal neuron
activate astrocytic CB1Rs, elevate intracellular Ca2+, and stimulate glutamate
(Glu) release that increase neurotransmitter release by activation of presyn-
aptic mGluRs in a neighboring synapse.
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Figure 7. The Sign of the Endocannabinoid-
Induced Synaptic Modulation Depends on
Specific Intercellular Signaling Pathways
(A) Proportion of synapses that showed DSE or
e-SP in control (n = 16) and PTX-treated slices
(n = 21).
(B) Schematic drawing representing the signaling
pathways that lead to DSE or e-SP.
(C) Synaptic responses (20 consecutive stimuli;
top traces) and averaged EPSCs (n = 50 stimuli;
bottom traces) before (basal) and after ND in
control and after perfusion with WIN.
(D) EPSC amplitudes from a representative
synapse in control and WIN.
(E) Relative changes from control basal values of
synaptic parameters before (basal) and after ND
in control and WIN (n = 7).
*p < 0.05, **p < 0.01and ***p < 0.001. Error bars
indicate SEM.
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Glia-Mediated Synaptic Modulation by Cannabinoidsstimulate the release of dopamine that lead to the modulation of
chemical and electrical synapses in the Mauthner cell of goldfish
(Cachope et al., 2007). Whether indirect synaptic modulation
induced by endocannabinoids through the stimulation of a
second neuromodulator is a general phenomenon in the nervous
system is an exciting possibility that needs to be investigated.
Furthermore, the possible involvement of glia-mediated mecha-
nisms in the endocannabinoid-induced modulation of neural
network activity, such as the recently reported endocannabi-
noid-mediated effects on the spinal locomotor activity of the
lamprey (Kyriakatos and El Manira, 2007), requires further
investigation.
The Heterogeneity of Endocannabinoid-Induced
Synaptic Modulation Depends on Spatially Controlled
Intercellular Signaling Pathways
Using the minimal stimulation technique, which stimulates single
or very few presynaptic fibers, we have found that endocannabi-
noids released from pyramidal neurons induced DSE, e-SP or no122 Neuron 68, 113–126, October 7, 2010 ª2010 Elsevier Inc.changes in synaptic transmission in
different synapses. The variety of the
synaptic modulation does not imply
heterogeneity of the synapses but is pro-
bably a consequence of the experimental
conditions, where single or very few
presynaptic fibers were stimulated and
a single pyramidal neuron was recorded.
Indeed, the different synaptic changes
observed in specific synapses cannot
be accounted for by different intrinsic
properties of synaptic terminals (e.g.,
differential expression of CB1 or mGluRs)
because they can undergo depression or
potentiation upon exogenous activation
of these receptors. Rather, they depend
on specific intercellular signaling path-
ways, whose activation is spatially con-
trolled (Figure 8A). Indeed, either directactivation of CB1Rs or indirect activation of mGluRs through
stimulation of astrocytes depends on the distance between the
synapse and the source of endocannabinoids.
Consequently, synapses located at relatively long distance of
the endocannabinoid source did not show DSE because CB1Rs
could not be activated due to the short range of action of
endocannabinoids (Chevaleyre and Castillo, 2004; Piomelli,
2003; Wilson and Nicoll, 2001), but they displayed mGluR-medi-
ated e-SP because astrocytes activated by endocannabinoids
could expand the signaling, through the extension of the intracel-
lular, and perhaps also intercellular, Ca2+ and the subsequent
glutamate release at relatively distant regions (Volterra and Mel-
dolesi, 2005; Haydon and Carmignoto, 2006; Perea et al., 2009).
In contrast, DSE was favored in synapses located at relatively
short distance of the endocannabinoid source because the
signaling cascade triggered by CB1R activation prevails over
that stimulated by mGluR activation (Figure 7). Although we
observed DSE in neurons whose somas were located between
20 and 60 mm away from the stimulated neuron, these results
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Figure 8. Endocannabinoids Induce Homo-
neuronal Synaptic Depression and Hetero-
neuronal Synaptic Potentiation
(A) Pr after ND (relative to basal values) versus
the respective distance between the somas of
the stimulating and recording neurons (n = 56
synapses).
(B) Schematic drawing depicting experimental
arrangement. Homoneuronal synapse (green)
corresponds to the recorded synapse onto the
depolarized neuron. Heteroneuronal synapse
(blue) corresponds to the recorded neighbor
synapse onto the unstimulated neuron.
(C) Synaptic responses (20 consecutive stimuli;
top traces) and averaged EPSCs (n = 50 stimuli;
bottom traces) before (basal) and after ND in heter-
oneuronal (left) and homoneuronal synapses
(right).
(D) EPSC amplitudes simultaneously recorded
from two representative heteroneuronal and
homoneuronal synapses. Zero time corresponds
to the beginning of the ND.
(E) Proportion of heteroneuronal and homoneruo-
nal synapses that showed DSE and e-SP after
ND (n = 33 paired synapses). ***p < 0.001.
(F) Scheme representing the endocannabinoid-
mediated signaling processes. Endocannabinoids
(ECBs) released by the pyramidal neuron acts
directly on the respective presynaptic terminal
leading to DSE in homoneuronal synapses.
ECBs acting on astrocytic CB1Rs elevate intracel-
lular Ca2+, stimulate glutamate release and poten-
tiate neurotransmitter release in heteroneuronal
synapses.
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Glia-Mediated Synaptic Modulation by Cannabinoidsare not necessarily inconsistent with short-range (<20 mm)
endocannabinoid signaling (Chevaleyre et al., 2006; Chevaleyre
and Castillo, 2004; Piomelli, 2003; Wilson and Nicoll, 2001)
because, due to the dendritic arborization, the modulated
synapses may be closer to the stimulated neuron than the
respective neuronal soma.
The spatially controlled sign of the endocannabinoid-induced
synaptic modulation may have important functional implications.
Furthermore, regulatory mechanisms that regulate the spatial
extensionofendocannabinoidsignaling,suchasdiffusionordegra-
dation of endocannabinoids, may have relevant consequences
because they can regulate the appearance of DSE or e-SP.
Subcellular Localization of Receptors
While DSE is known to be mediated by activation of CB1Rs
located at presynaptic terminals (see e.g., Alger, 2002; Cheva-
leyre et al., 2006), present results indicate that e-SP is indirectly
mediated by activation of CB1Rs located in astrocytes. This idea
is supported by the fact that astrocytes express functional
CB1Rs (Stella, 2004; Navarrete and Araque, 2008) that upon
activation elevate the intracellular Ca2+ and stimulates glutamateNeuron 68, 113–126release (Navarrete and Araque, 2008),
and that e-SP is mediated by mGluRs
and requires both CB1R activation and
astrocytic Ca2+ elevations (Figures 4–6).Astrocytic CB1R activation stimulates glutamate release that
then activates group I mGluRs to induce e-SP. Several evidence
indicate that these mGluRs are located presynaptically: (1) e-SP
is characterized by the enhancement of transmitter release prob-
ability without changes in synaptic potency, which indicates
a presynaptic rather than a postsynaptic underlying mechanism;
(2) e-SP is accompanied by changes in the paired-pulse facilita-
tion (Figures S1A and S1B), which is consistent with a presyn-
aptic mechanism; (3) a transient enhancement of transmitter
release probability could be induced by application of themGluR
agonist DHPG when the postsynaptic signaling cascade of
mGluRs was blocked by dialyzing the postsynaptic neuron
with GDPbS. Taken together, these results strongly indicate
that e-SP is mediated by activation of presynaptic mGluRs.
However, anatomical evidence for presynaptic mGluR1 at
Schaffer collaterals awaits confirmation.
Physiological Consequences of Endocannabinoid-
Mediated Synaptic Modulation
In contrast to the large amount of evidence indicating the
relevance of the astrocyte Ca2+ signal in neurophysiology (for, October 7, 2010 ª2010 Elsevier Inc. 123
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Glia-Mediated Synaptic Modulation by Cannabinoidsreviews see Haydon and Carmignoto, 2006; Perea et al., 2009),
recent reports have questioned its physiological importance
(Agulhon et al., 2010). Present data demonstrate that astrocyte
Ca2+ signal triggered by an endogenous ligand (i.e., endocanna-
binoids) released by physiological events (i.e., neuronal action
potentials) is competent to modulate synaptic transmission
properties.
Present results indicate that astrocytes exert a subtle modula-
tory effect on the activity of synapses that was overlooked when
analyzing the effects on neurotransmission at large scale.
Indeed, the fact that homoneuronal synapses only showed
DSE suggests that the endocannabinoid-induced synaptic
depression mediated by direct activation of presynaptic
CB1Rs is the prevailing mechanism over the astrocyte-induced
synaptic potentiation. Consequently, it is not surprising that
endocannabinoid-induced synaptic potentiation remained
elusive when synaptic transmission was analyzed by massive
stimulation of axons or when exogenous agonists were applied.
Therefore, our results widen our view of the delicate regulatory
role of astrocytes in neurotransmission, whichmay be concealed
by stronger modulatory mechanisms, but which can be revealed
by analyzing synaptic transmission in fine detail.
In conclusion, astrocytes potentiate hippocampal synaptic
efficacy upon stimulation by endocannabinoids, indicating that
they are an integral part of the endocannabinoid system. These
results expand our view of endocannabinoid signaling as well
as astrocytic function on synaptic physiology, and indicate that
astrocytes are involved in relevant phenomena of brain function.
EXPERIMENTAL PROCEDURES
Hippocampal Slice Preparation
Hippocampal slices were obtained from C57BL/6 mice (13–18 days old). In
some cases, slices from CB1 receptor knock-out mice, generously donated
by Dr. A. Zimmer, were used (Zimmer et al., 1999). All the procedures for
handling and sacrificing animals followed the European Commission guide-
lines (86/609/CEE). Animals were anaesthetized and decapitated. The brain
was rapidly removed and placed in ice-cold artificial cerebrospinal fluid
(ACSF). Slices (350–400 mm thick) were incubated during > 1 hr at room
temperature (21C–24C) in ACSF that contained (in mM): NaCl 124, KCl
2.69, KH2PO4 1.25, MgSO4 2, NaHCO3 26, CaCl2 2 and glucose 10, and
was gassed with 95% O2/5% CO2 (pH = 7.3). Slices were then transferred
to an immersion recording chamber and superfused at 2 ml/min (the chamber
volume was replaced in 10-12 min) with gassed ACSF including 0.05 mM
Picrotoxin and 100 mM Saclofen to block GABAA and GABAB receptors
respectively. Cells were visualized under an Olympus BX50WI microscope
(Olympus Optical, Tokyo, Japan) equipped with infrared and differential inter-
ference contrast imaging devices, and with a 403 water-immersion objective.
Electrophysiology
Simultaneous electrophysiological recordings from two CA1 pyramidal
neurons were made using the whole-cell patch-clamp technique. Patch elec-
trodes had resistances of 3–10 MU when filled with the internal solution that
contained (in mM) for pyramidal neurons: KGluconate 135, KCl 10, HEPES
10, MgCl 1, ATP-Na2 2 (pH = 7.3). Recordings were obtained with PC-ONE
amplifiers (Dagan Instruments, Minneapolis, MN). Fast and slow whole-cell
capacitances were neutralized and series resistance was compensated
(z70%), and the membrane potential was held at 70 mV. Electrophysiolog-
ical properties were monitored before and at the end of the experiments.
Series and input resistances were monitored throughout the experiment using
a 5 mV pulse. Recordings were considered stable when the series and input
resistances, resting membrane potential and stimulus artifact duration did not124 Neuron 68, 113–126, October 7, 2010 ª2010 Elsevier Inc.change >20%. Furthermore, I-V curves and firing pattern before and at the end
of the experiments were similar. Cells that did not meet these criteria were dis-
carded. Signals were fed to a Pentium-based PC through a DigiData 1440A
interface board. Signals were filtered at 1 KHz and acquired at 10 KHz
sampling rate. The pCLAMP 10.2 (Axon instruments) software was used for
stimulus generation, data display, acquisition and storage. We performed
paired whole-cell recordings from two CA1 pyramidal neurons (distance of
the somas < 150 mm). In some experiments astrocytes were patched with
4–9 MU electrodes filled with an intracellular solution containing (in mM):
1 MgCl2, 8 NaCl, 2 ATP, 0.4 GTP, 10 HEPES, and either 40 mM BAPTA or
10 mM GDPbS, titrated with KOH to pH 7.2–7.25 and adjusted to 275–
285 mOsm. The Ca2+ chelator BAPTA and GDPbS were included to prevent
Ca2+ elevations and G protein-mediated intracellular signaling, respectively,
in astrocytes. Astrocyte whole-cell recordings lasted at least 30 min to allow
the dialysis of BAPTA or GDPbS throughout the gap-junction connected astro-
cyte network. We performed control experiments similar to regular experi-
ments but placing the BAPTA containing pipette in the bath without achieving
whole-cell mode. After 1–2 min of positive pressure, the pipette was with-
drawn. The subsequent analysis of synaptic transmission properties indicate
that both DSE and e-SP could be evoked by ND (n = 12; 33% and 33%,
respectively).
In some cases, the stimulating neuron was recorded in current-clamp
conditions and depolarizing pulses of different durations were applied to
evoke trains of action potentials. When long duration pulses induced strong
neuronal firing adaptation, shorter repetitive pulses were delivered. The
duration of the depolarizing pulses was varied to obtain different number of
action potentials.
Synaptic Stimulation
Theta capillaries (2–5 mm tip) filled with ACSF was used for bipolar minimal
stimulation. The electrodes were connected to a stimulator S-910 through
an isolation unit and placed in the stratum radiatum to stimulate Schaffer
collateral (SC) afferents. Single pulses (250 ms duration) or paired pulses
(50 ms interval) were continuously delivered at 0.33 Hz. The stimulus intensity
(5-10 mA) was adjusted to meet the conditions that putatively stimulate single
or very few presynaptic fibers (c.f. Dobrunz and Stevens, 1997; Isaac et al.,
1996; Perea and Araque, 2007; Raastad, 1995), and was unchanged during
the experiment. Recordings that did not meet these criteria and synapses
that did not show amplitude stability of EPSCs were rejected. The synaptic
parameters analyzed were: synaptic efficacy (mean peak amplitude of all
responses including failures); synaptic potency (mean peak amplitude of the
successes); probability of release (Pr, ratio between number of successes
versus total number of stimuli); and paired-pulse facilitation (PPF = [(2nd
EPSC – 1st EPSC)/1st EPSC]). Synaptic parameters were determined from
50 stimuli before (basal) and after stimulus (ND or APs). Two consecutive
responses to ND were averaged. To illustrate the time course of ND-induced
effects, synaptic parameters were grouped in 33 s bins. EPSC amplitude
was determined as the peak current amplitude (2–9 ms after stimulus) minus
the mean baseline current (20–30 ms before stimulus). A response was con-
sidered a failure if the amplitude of the current was < 3 times the standard devi-
ation of the baseline current (0.7–2.3 pA) and was verified by visual inspection.
The presence of e-SP or DSE was assessed in individual synapses if statis-
tical significant differences were found between Pr values obtained 96 s before
and after ND or APs. To characterize pharmacologically both phenomena, we
first identified specific synapses undergoing either DSE or e-SP in control
conditions and then analyzed the effects of subsequent superfusion of
pharmacological agents on the synapses previously identified. Because in
experiments involving CB1R knockout mice, BAPTA-loaded cells, or PTX
treatment, the previous identification of synapses in control was unfeasible,
we compared the incidence of DSE and e-SP (i.e., the proportion of synapses
that showed either phenomenon) in parallel control and test slices.
To asses that effects observed after PTX treatment were specifically due to
the toxin, we tested the effects of slice preincubation with 7.5 mg/ml heat-inac-
tivated PTX for 3.5–9 hr. In 9 synapses recorded from 4 heat-inactivated-PTX
treated slices and in 21 synapses from 6 control slices, the incidence of DSE
and e-SP was similar (33% and 37% for DSE, and 33% and 33% for e-SP,
in control and heat-inactivated PTX, respectively; p > 0.05).
Neuron
Glia-Mediated Synaptic Modulation by CannabinoidsExperiments were performed at room temperature (21C–24C), unless
stated otherwise. In some cases, temperature of the bath solution was
adjusted and controlled to 24C and 34C with a temperature controller
TC-324B (Warner Instruments Co.), using a probe immersed in the recording
chamber. In some cases the temperature was elevated from 24C to 34C,
and in other cases it was decreased from 34C to 24C. We then compared
the relative effects of ND on synaptic transmission properties at both temper-
atures on the same synapses. Evidence of the effective change of temperature
is provided by the relatively higher basal Pr at 34C than at 24C (see Figure S3)
as well as by the faster EPSC decay time course (9.1 ± 0.4 and 6.2 ± 0.2 ms at
34C and 24C, respectively; n = 59; p < 0.001).
The effects of pharmacological agents were tested at < 40min after entering
whole-cell mode in the stimulating neuron, i.e., before a significant rundown of
the ND-evoked effect took place (see Figure S1E). Data are expressed as
mean ± SEM. Results were compared using a two-tailed Student’s t test
(a = 0.05), or the Chi-square test when comparing the proportion of DSE
and e-SP. Statistical differences were established with p < 0.05 (*), p < 0.01
(**), and p < 0.001 (***).Ca2+ Imaging
Ca2+ levels in astrocytes located in the stratum radiatum of the CA1 region
of the hippocampus were monitored by fluorescence microscopy using the
Ca2+ indicator fluo-4 (Molecular Probes, Eugene, OR). Slices were incubated
with fluo-4-AM (2–5 ml of 2 mM dye were dropped over the hippocampus,
attaining a final concentration of 2–10 mM and 0.01% of pluronic) for 20–
30 min at room temperature. In these conditions, most of the cells loaded
were astrocytes (Araque et al., 2002; Kang et al., 1998; Nett et al., 2002; Parri
et al., 2001; Perea and Araque, 2005) as confirmed in some cases by their
electrophysiological properties. Astrocytes were imaged using a CCD camera
(Retiga EX; Qimaging, Canada) attached to the Olympus microscope. Cells
were illuminated during 200–500 ms with a xenon lamp at 490 nm using
a monochromator Polychrome II (T.I.L.L. Photonics, Planegg, Germany), and
images were acquired every 0.5–1 s. The monochromator Polychrome II and
the CCD camera were controlled and synchronized by the IP Lab software
(BD Biosciences, MD) that was also used for quantitative epifluorescence
measurements. Intracellular Ca2+ signal of stratum radiatum astrocytes was
monitored from cells located within a 150 mm wide region around the
stimulated neuron and perpendicular to the stratum pyramidale. Ca2+ varia-
tions recorded at the soma of the cells were estimated as changes of the
fluorescence signal over baseline (DF/F0), and cells were considered to
respond to the stimulation when DF/F0 increased three times the standard
deviation of the baseline for at least two consecutive images and with a
delay% 15 s after the stimulation.
The astrocyte Ca2+ signal was quantified from the probability of occurrence
of a Ca2+ spike and the Ca2+ oscillation frequency. The Ca2+ spike probability
was calculated from the number of Ca2+ elevations grouped in 5 s bins
recorded from 6 to 14 astrocytes in the field of view. The time of occurrence
was considered at the onset of the Ca2+ spike. The Ca2+ oscillation frequency
was obtained from the number of Ca2+ spikes occurring in 6 to 14 astrocytes in
the field of view during 50 s periods before (basal) and after the onset of the
neuronal depolarization. To test the effects of ND or APs on Ca2+ spike prob-
ability under different conditions, the respective mean basal (50 s before ND)
andmaximum Ca2+ spike probability (i.e., 5–10 s after ND) from different slices
were averaged and compared. Mean values were obtained from at least 4
slices in each condition. Successive ND consistently evoked successive
increases of the astrocyte Ca2+ spike probability (see Navarrete and Araque,
2008).Ca2+ Uncaging by UV-Flash Photolysis
In photostimulation experiments, single astrocytes were electrophysiologically
recorded with patch pipettes filled with the internal solution containing 5 mM
NP-EGTA (and 50 mM fluo-4 to monitor Ca2+ levels). Ca2+ uncaging was
achieved by delivering train pulses (1 ms duration, 6–15 mW) of UV light
(340–380 nm) at 2 Hz during 5 s to the soma and processes of the recorded
astrocyte (optical window of 15-25 mm diameter) using a flash photolysis
system (Rapp OptoElectronic, Hamburg, Germany).Drugs and Chemicals
1,2-bis(2-aminophenoxy)ethane-N,N,N0,N0-tetraacetate (BAPTA); N-(Piperidin-
1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxa-
mide (AM-251); 2-Methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP),
(S)-(+)-a-amino-4-carboxy-2-methylbenzeneacetic acid (LY367385), (RS)-3-
Amino-2-(4-chlorophenyl)propylsulfonic acid (saclofen), thapsigargin and (RS)-
3,5-DHPG were purchased from Tocris Cookson (Bristol, UK), and Fluo-4-AM
and o-nitrophenyl EGTA, tetrapotassium salt (NP-EGTA) (Molecular Probes,
Eugene, OR). All other drugs were from Sigma.
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